120
Participants
Start Date
January 2, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
zinc acetate
Participants in Control group. They will continue the SoC + 3 tablets of placebo and participants in Zinc supplementation group. Tablets will be separated 12h (just in case the ART is based in Integrase Inhibitors (INSTI)) during supplementation for 16 weeks with 3 tablets of zinc (83mg Zinc acetate/tablet).
Placebo
participants in Control group. They will continue the SoC + 3 tablets of placebo. 3 tablets separated 12h from ART during 16 weeks
Hospital de Sabadell
OTHER
Parc de Salut Mar
OTHER